Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07733037) titled 'Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia' on July 23.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Peking University People's Hospital
Condition:
Immune Thrombocytopenia (ITP)
Intervention:
Drug: Fecal microbiota transplantation
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: January 10, 2026
Target Sample Size: 42
Countries of Recruitment:
C...